Zhangzhou Pientzehuang Pharmaceutical Co Ltd Net Asset Momentum
Zhangzhou Pientzehuang Pharmaceutical Co Ltd net asset momentum. Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) recorded a net asset momentum of 1.7% as of December 2025, with net assets of CN¥15.09 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Zhangzhou Pientzehuang Pharmaceutical Co shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
Net asset momentum of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025. This chart tracks Zhangzhou Pientzehuang Pharmaceutical Co Ltd's year-over-year net asset growth across 26 annual reporting periods from 2000 to 2025. The most recent momentum reading is +1.7%, with net assets of CN¥15.09 Billion CNY as of December 2025. Check 600436 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Net Asset Momentum by Year (2000–2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd net asset momentum by year from 2000 to 2025. The table below shows the complete annual net asset history for Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025, covering 26 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Zhangzhou Pientzehuang Pharmaceutical Co.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥15.09 Billion | CN¥17.56 Billion | CN¥2.47 Billion | ▲ +1.7% |
| 2024 | CN¥14.84 Billion | CN¥17.54 Billion | CN¥2.70 Billion | ▲ +6.6% |
| 2023 | CN¥13.92 Billion | CN¥17.08 Billion | CN¥3.16 Billion | ▲ +17.7% |
| 2022 | CN¥11.82 Billion | CN¥14.60 Billion | CN¥2.78 Billion | ▲ +16.6% |
| 2021 | CN¥10.14 Billion | CN¥12.50 Billion | CN¥2.36 Billion | ▲ +22.8% |
| 2020 | CN¥8.26 Billion | CN¥10.21 Billion | CN¥1.95 Billion | ▲ +18.5% |
| 2019 | CN¥6.97 Billion | CN¥8.81 Billion | CN¥1.84 Billion | ▲ +31.3% |
| 2018 | CN¥5.31 Billion | CN¥6.66 Billion | CN¥1.35 Billion | ▲ +19.9% |
| 2017 | CN¥4.43 Billion | CN¥5.65 Billion | CN¥1.22 Billion | ▲ +18.0% |
| 2016 | CN¥3.75 Billion | CN¥5.04 Billion | CN¥1.29 Billion | ▲ +13.5% |
| 2015 | CN¥3.30 Billion | CN¥4.05 Billion | CN¥751.60 Million | ▲ +10.6% |
| 2014 | CN¥2.99 Billion | CN¥3.65 Billion | CN¥662.34 Million | ▲ +15.2% |
| 2013 | CN¥2.59 Billion | CN¥3.26 Billion | CN¥667.05 Million | ▲ +66.6% |
| 2012 | CN¥1.56 Billion | CN¥2.23 Billion | CN¥675.22 Million | ▲ +30.8% |
| 2011 | CN¥1.19 Billion | CN¥1.57 Billion | CN¥379.69 Million | ▲ +9.7% |
| 2010 | CN¥1.08 Billion | CN¥1.45 Billion | CN¥362.97 Million | ▲ +26.4% |
| 2009 | CN¥857.19 Million | CN¥1.28 Billion | CN¥427.35 Million | ▲ +14.0% |
| 2008 | CN¥752.09 Million | CN¥1.07 Billion | CN¥318.45 Million | ▼ -0.9% |
| 2007 | CN¥758.85 Million | CN¥970.88 Million | CN¥212.03 Million | ▲ +22.2% |
| 2006 | CN¥621.09 Million | CN¥730.62 Million | CN¥109.53 Million | ▲ +2.1% |
| 2005 | CN¥608.07 Million | CN¥693.63 Million | CN¥85.56 Million | ▲ +12.8% |
| 2004 | CN¥539.08 Million | CN¥558.77 Million | CN¥19.69 Million | ▼ -2.6% |
| 2003 | CN¥553.59 Million | CN¥594.99 Million | CN¥41.40 Million | ▲ +257.6% |
| 2002 | CN¥154.81 Million | CN¥325.79 Million | CN¥170.99 Million | ▲ +6.0% |
| 2001 | CN¥146.02 Million | CN¥270.36 Million | CN¥124.34 Million | ▲ +3.3% |
| 2000 | CN¥141.35 Million | CN¥258.68 Million | CN¥117.33 Million | — |